Category - Any -CorporateScience Apply Interview of Eric Vivier “The new generation of NK cell therapies” Fri, 02/05/2021 - 08:00 Interview Eric Vivier "The new generation of NK cell therapies" Read more about Interview of Eric Vivier “The new generation of NK cell therapies” How NK cells work Fri, 01/01/2021 - 12:00 Read more about How NK cells work IUIS-Frontiers Webinar Series on COVID-19: Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis - Eric Vivier Tue, 06/23/2020 - 10:45 Read more about IUIS-Frontiers Webinar Series on COVID-19: Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis - Eric Vivier Avdoralimab in COVID-19 Tue, 04/28/2020 - 12:15 Read more about Avdoralimab in COVID-19 Nasdaq #BehindTheBell (October 17, 2019) Wed, 10/30/2019 - 09:45 Read more about Nasdaq #BehindTheBell (October 17, 2019) Pagination Current page 1 Page 2 Page 3 Page 4 Next page Next › Last page Last »
Interview of Eric Vivier “The new generation of NK cell therapies” Fri, 02/05/2021 - 08:00 Interview Eric Vivier "The new generation of NK cell therapies" Read more about Interview of Eric Vivier “The new generation of NK cell therapies”
IUIS-Frontiers Webinar Series on COVID-19: Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis - Eric Vivier Tue, 06/23/2020 - 10:45 Read more about IUIS-Frontiers Webinar Series on COVID-19: Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis - Eric Vivier
Nasdaq #BehindTheBell (October 17, 2019) Wed, 10/30/2019 - 09:45 Read more about Nasdaq #BehindTheBell (October 17, 2019)
